Recombinant antigen p30 (SAG1) for Toxoplasma gondii

Major surface antigen p30 (SAG1) induces significant levels of p30 antibodies in all patients with toxoplasmosis. It has been described in the literature that this 30 kDa protein has the capacity to carry out the serological analysis of Toxoplasma infections.

Disease caused mainly to warm-blooded animals.

More information about Toxoplasmosis caused by Toxoplasma gondii.

Name

p30 (SAG1)

Description

Major surface antigen

Gene

SAG1

Purity

> 95% by observation on SDS-PAGE electrophoresis

Cat number

SKU	Source	Applications	In-house validation	Details
RAG0011	E. coli	WB, DB, IE, DE, CLIA, LF	ELISA WB
RAG0030	P. pastoris	WB, DB, IE, DE, CLIA, LF	ELISA WB

Due to the nonspecific interaction with anti-CCDs present in normal human or animal sera, we strongly recommend using our blocker SOR0001 on the analyzed sera in any immunoassay.

Formats

Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk
* under availability, for liquid format

Related proteins

ChimToxo1 p29 (GRA7) p35 (GRA8)

Also avaliable for diagnosis of Toxoplasmosis caused by Toxoplasma gondii in humans

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.